Herbert Stadler

Dr. Herbert Stadler is a Cu-Founder of Curexsys and serves as Chief Executive Officer at Stage Cell Therapeutics. He is an Angel Investor. He is also the Chairman of BellaSeno. Over the last two decades, Herbert Stadler has built a track record as one of Germany's most active biotech entrepreneurs. He has founded or co-founded several companies including Biometra GmbH, IBA GmbH, DeveloGen AG, Synaptic Systems GmbH and Affectis AG. Herbert Stadler is a neurochemist by training. He obtained his Ph.D. at the Freie University of Berlin and later his lecture qualification ("Habilitation") at the University of Gottingen; he was a group leader at the Max-Planck Institute of Biophysical Chemistry in Gttingen. He served as a Board Member at Provecs Medical.